Improved effects of a double suicide gene system on prostate cancer cells by targeted regulation of prostate-specific membrane antigen promoter and enhancer

International Journal of Urology

Volumn 15, Issue 5, 2008, Pages 442-448

  Zhang, Peng ^a   Zeng, Hao ^a   Wei, Qiang ^a   Lu, Yiping ^a   Li, Xiang ^a   Wang, Jia ^a   Zhao, Fujun ^b   Li, Hong ^a  

^a SICHUAN UNIVERSITY   (China)

^b SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

5 flurocytosine; Cytosine deaminase; Prostate cancer; Prostate specific membrane antigen; Targeted regulating; Uracil phosphoribosyltransferase

Indexed keywords

CYTOSINE DEAMINASE; ENHANCED GREEN FLUORESCENT PROTEIN; FLUCYTOSINE; FLUOROURACIL; PROSTATE SPECIFIC MEMBRANE ANTIGEN; URACIL PHOSPHORIBOSYLTRANSFERASE;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER GENE THERAPY; CELL CYCLE; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; ENHANCER REGION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; RECOMBINANT PLASMID; SUICIDE GENE THERAPY; TARGET CELL DESTRUCTION; TREATMENT OUTCOME;

ANTIGENS, SURFACE; CELL LINE, TUMOR; CYTOSINE DEAMINASE; ENHANCER ELEMENTS (GENETICS); GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; MALE; PENTOSYLTRANSFERASES; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; TARGETED GENE REPAIR;

EID: 43049147982     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02034.x     Document Type: Article

References (26)

1. Jemal A, Murray T, Ward E et al. Cancer statistics, 2007. CA Cancer J. Clin. 2007 57 : 43 6.
2. Brawley OW, Giovannucci E, Kramer BS. Epidemiology of prostate cancer. In : Vogelzang NJ, Shipely WU, Scardino PT, Coffey DS, Miles BJ (eds). Comprehensive Textbook of Genitourinary Oncology. Lippincott Williams Wilkins, Philadelphia, PA, 2000 534 44.
3. Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res. 1986 46 : 5276 18.
4. Bostwick DG, Pacelli A, Michael B et al. Prostate specific membrane antigen expression in PIN and adenocarcinoma. Cancer 1998 82 : 2256 61.
5. Kawakami M, Nakayama J. Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hybridization. Cancer Res. 1997 57 : 2321 4.
6. Wright GL Jr, Grob BM, Haley C et al. Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy. Urology 1996 48 : 326 34.
7. Zeng H, Wu Q, Li H et al. Construction of prostate-specific expressed recombinant plasmids with high transcriptional activity of prostate-specific membrane antigen (PSMA) promoter/enhancer. J. Androl. 2005 26 : 215 21.
8. Hayden MS, Linsley PS, Wallace AR et al. Cloning, overexpression, and purification of cytosine deaminase from Saccharomyces cerevisiae. Protein Expr. Purif. 1998 12 : 173 84.
9. Koechlin BA, Rubio F, Palmer S et al. The metabolism of 5-fluorocytosine-2-14-C and of cytosine-14-C in the rat and the disposition of 5-fluoro- cytosine-2-14-C in man. Biochem. Pharmacol. 1966 15 : 435 46.
10. Ross C. Comparison of incorporation and metabolism of RNA pyrimidine nucleotide precursors in leaf tissues. Plant Physiol. 1965 40 : 65 73.
11. Danielsen S, Kilstrup M, Barilla K et al. Characterization of the Escherichia coli codBA operon encoding cytosine permease and cytosine deaminase. Mol. Microbiol. 1992 6 : 1335 44.
12. Kornberg A, Baker T. DNA Synthesis. In : Freeman WM (ed.). DNA Replication. Freeman, New York, NY, 1992 53 100.
13. Neuhard J, Kelln RA. Biosynthesis and conversion of pyrimidines. In : Neidhart FC, Ingraham JL, Low KB, Magasanik B, Schaechter M, Umbarger HE (eds). Escherichia coli and Salmonella typhimurium: Cellular and Molecular Biology. American Society for Microbiology, Washington, DC, 1996 580 599.
14. Bridgewater JA, Springer CA, Knox RJ et al. Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the pro-drug CB1954. Eur. J. Cancer 1995 31A : 2362 70.
15. Tiraby M, Cazaux C, Baron M et al. Concomitant expression of E. coli cytosine deaminase and uracil phosphoribosyltransferase improves the cytotoxicity of 5-fluorocytosine. FEMS Microbiol. Lett. 1998 167 : 41 9.
16. Zeng H, Wei Q, Huang R et al. Recombinant adenovirus mediated prostate- specific enzyme pro-drug gene therapy regulated by prostate-specific membrane antigen (PSMA) enhancer/promoter. J. Androl. 2007 28 : 827 35. Epub 2007 May 23.
17. Koyama F, Sawada H, Hirao T et al. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of Escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine. Cancer Gene Ther. 2000 7 : 1015 22.
18. Chung-Faye GA, Chen MJ, Green NK et al. In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase. Gene Ther. 2001 8 : 1547 55.
19. Rogulski KR, Kim JH, Kim SH et al. Glioma cells transduced with an Escherichia coli CD/HSV-ITK fusion gene exhibit enhanced metabolic suicide and radiosensitivity. Hum. Gene Ther. 1997 8 : 73 85.
20. Liu H, Moy P, Kim S et al. Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also reacts with tumor vascular endothelium. Cancer Res. 1997 57 : 3629 34.
21. Silver DA, Pellicer I, Fair WR et al. Prostate specific membrane antigen expression in normal and malignant human tissue. Clin. Cancer Res. 1997 3 : 81 5.
22. Chang SS, Reuter VE, Heston WD et al. Five different anti-prostate- specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res. 1999 59 : 3192 8.
23. Israeli RS, Powell CT, Corr JG et al. Expression of the prostate-specific membrane antigen. Cancer Res. 1994 54 : 1807 11.
24. Troyer JK, Beckett ML, Wright GL et al. Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and bodyfluids. Int. J. Cancer 1995 62 : 552 8.
25. Wright GL Jr, Haley C, Beckett ML et al. Expression of prostate-specific membrane antigen in normal, benign and malignant prostate tissues. Urol. Oncol. 1995 1 : 18 28.
26. Chang SS, Reuter VE, Heston WD, Gaudin PB. Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen. Urology 2001 57 : 801 5.